THE European Medicines Agency’s
Committee for Medicinal Products
for Human Use (CHMP) has
recommended the approval of
insulin degludec, a new basal
analogue insulin for the treatment
of diabetes mellitus in adults.
The drug is introduced in a
pre-filled pen in two formulations –
100 units/ml and 200 units/ml, and
is the first insulin approved in
Europe at a higher strength than
the EU-wide standard of 100 units/ml.The above article was sent to subscribers in Pharmacy Daily's issue from 23 Oct 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 23 Oct 12
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.